Home › Funds › Vestal Point Capital, LP › RGEN

Vestal Point Capital, LP position in RGEN

REPLIGEN CORP · Health Care

Vestal Point Capital, LP reported holding 400,000 shares of RGEN (REPLIGEN CORP) in its Q2 2026 13F filing — a position valued at US$54.6M, representing 1.28% of its reported portfolio and ranking #27 among its reported holdings. Vestal Point Capital, LP has disclosed RGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)400.00K sh
Reported value held$54.58M
Portfolio Weight1.28%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's RGEN position evolved

Vestal Point Capital, LP first disclosed a stake in RGEN in Q3 2025 at 400,000 shares (US$53.5M). The position peaked in Q1 2026 at 925,000 shares, worth US$109.0M. Across 4 filings, Vestal Point Capital, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 400,000 shares valued at US$54.6M — a reduction of -525,000 shares quarter over quarter.. Notable position changes include a 79% trim in Q4 2025 (shares fell 28% over the following quarter), a 1014% increase in Q1 2026 (shares rose 16% over the following quarter), a 57% trim in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 400.00K $53.47M New
Q4 2025 83.00K $13.60M Reduce
Q1 2026 925.00K $108.98M Add
Q2 2026 400.00K $54.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Vestal Point Capital, LP held RGEN?

Vestal Point Capital, LP has disclosed RGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Vestal Point Capital, LP's current position in RGEN?

As of Q2 2026, Vestal Point Capital, LP holds 400.00K shares of RGEN (REPLIGEN CORP), valued at $54.58M, representing 1.28% of its reported portfolio and ranking #27.

Has Vestal Point Capital, LP been buying or selling RGEN?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in RGEN. The position peaked in Q1 2026 at 925.00K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.